Here's How This Pharmaceutical Giant Is Protecting Itself From President Trump's Tariffs. Should It Matter to Investors?

A new deal with the White House could lead to a new sales channel that bypasses health insurance companies.As President Donald Trump's escalating tariff policies threaten to raise costs across global supply chains, one pharmaceutical giant is taking steps to protect its bottom line. On Sept. 30, Pfizer (PFE -1.81%) became the first big pharma company to agree to implement most-favored-nation pricing for the U.S.As you may recall, Trump said the White House would impose a 100% tariff on any branded pharmaceu ...